酮洛芬在山羊体内反复单独或联合头孢醌的药代动力学。

IF 1.7 4区 农林科学 Q3 PHARMACOLOGY & PHARMACY
Duygu Durna Corum, Orhan Corum, Mario Giorgi, Serafettin Kartal, Erdinc Turk, Fatih Sakin, Huseyin Donmez, Kamil Uney
{"title":"酮洛芬在山羊体内反复单独或联合头孢醌的药代动力学。","authors":"Duygu Durna Corum, Orhan Corum, Mario Giorgi, Serafettin Kartal, Erdinc Turk, Fatih Sakin, Huseyin Donmez, Kamil Uney","doi":"10.1111/jvp.70008","DOIUrl":null,"url":null,"abstract":"<p><p>This work was aimed at investigating the pharmacokinetic changes after repeated administration of ketoprofen (3 mg/kg, IM, once a day for 5 days) to goats either alone or in combination with cefquinome (2 mg/kg, IM, once a day for 5 days). The study was carried out on six goats according to a balanced, open, two-phase, cross-pharmacokinetic design. The plasma ketoprofen concentrations were measured using HPLC-UV, and the pharmacokinetic data were estimated using a non-compartmental analysis. After the first dose of ketoprofen, the terminal elimination half-life (t<sub>1/2ʎz</sub>), area under the plasma concentration-time curve (AUC<sub>0-last</sub>), and peak plasma concentration (C<sub>max</sub>) were 1.47 h, 12.23 h*μg/mL, and 6.06 μg/mL, respectively. The last dose of ketoprofen resulted in significant variations in t<sub>1/2ʎz</sub> and AUC<sub>0-last</sub> values compared to the first dose, but C<sub>max</sub> was similar. Cefquinome administration caused significant differences in the t<sub>1/2ʎz</sub>, AUC<sub>0-last</sub>, and C<sub>max</sub> of ketoprofen. There was no variation in T<sub>max</sub> between the first and final doses or between treatment groups. The accumulation ratio of ketoprofen was 1.32 and 0.76 when used alone and in combination with cefquinome, respectively. Repeated administration of ketoprofen alone or with cefquinome altered its disposition; therefore, the efficacy of ketoprofen when used alone or in combination with cefquinome in goats should be determined, and the dosage regimen should be re-evaluated.</p>","PeriodicalId":17596,"journal":{"name":"Journal of veterinary pharmacology and therapeutics","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ketoprofen Pharmacokinetics in Goats Following Repeated Treatment Alone or in Combination With Cefquinome.\",\"authors\":\"Duygu Durna Corum, Orhan Corum, Mario Giorgi, Serafettin Kartal, Erdinc Turk, Fatih Sakin, Huseyin Donmez, Kamil Uney\",\"doi\":\"10.1111/jvp.70008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This work was aimed at investigating the pharmacokinetic changes after repeated administration of ketoprofen (3 mg/kg, IM, once a day for 5 days) to goats either alone or in combination with cefquinome (2 mg/kg, IM, once a day for 5 days). The study was carried out on six goats according to a balanced, open, two-phase, cross-pharmacokinetic design. The plasma ketoprofen concentrations were measured using HPLC-UV, and the pharmacokinetic data were estimated using a non-compartmental analysis. After the first dose of ketoprofen, the terminal elimination half-life (t<sub>1/2ʎz</sub>), area under the plasma concentration-time curve (AUC<sub>0-last</sub>), and peak plasma concentration (C<sub>max</sub>) were 1.47 h, 12.23 h*μg/mL, and 6.06 μg/mL, respectively. The last dose of ketoprofen resulted in significant variations in t<sub>1/2ʎz</sub> and AUC<sub>0-last</sub> values compared to the first dose, but C<sub>max</sub> was similar. Cefquinome administration caused significant differences in the t<sub>1/2ʎz</sub>, AUC<sub>0-last</sub>, and C<sub>max</sub> of ketoprofen. There was no variation in T<sub>max</sub> between the first and final doses or between treatment groups. The accumulation ratio of ketoprofen was 1.32 and 0.76 when used alone and in combination with cefquinome, respectively. Repeated administration of ketoprofen alone or with cefquinome altered its disposition; therefore, the efficacy of ketoprofen when used alone or in combination with cefquinome in goats should be determined, and the dosage regimen should be re-evaluated.</p>\",\"PeriodicalId\":17596,\"journal\":{\"name\":\"Journal of veterinary pharmacology and therapeutics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of veterinary pharmacology and therapeutics\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.1111/jvp.70008\",\"RegionNum\":4,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of veterinary pharmacology and therapeutics","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/jvp.70008","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在研究酮洛芬(3 mg/kg, IM,每天1次,连用5天)单独或与头孢醌(2 mg/kg, IM,每天1次,连用5天)对山羊的药代动力学变化。本研究采用平衡、开放、两期、交叉药代动力学设计对6只山羊进行试验。采用高效液相色谱-紫外分光光度法测定血浆酮洛芬浓度,采用非区室分析法估计药代动力学数据。首次给药后,酮洛芬的终末消除半衰期(t1/2)、血药浓度-时间曲线下面积(AUC0-last)和血药峰值浓度(Cmax)分别为1.47 h、12.23 h*μg/mL和6.06 μg/mL。与第一次给药相比,最后一次给药酮洛芬导致t1/2 * z和AUC0-last值有显著变化,但Cmax相似。头孢喹诺对酮洛芬的t1/2、AUC0-last和Cmax均有显著性影响。在第一次和最后一次剂量之间或治疗组之间Tmax没有变化。酮洛芬单用和与头孢醌合用的累积比分别为1.32和0.76。反复服用酮洛芬或头孢醌可改变其倾向;因此,应确定酮洛芬在山羊中单独使用或与头孢醌合用的疗效,并重新评估给药方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ketoprofen Pharmacokinetics in Goats Following Repeated Treatment Alone or in Combination With Cefquinome.

This work was aimed at investigating the pharmacokinetic changes after repeated administration of ketoprofen (3 mg/kg, IM, once a day for 5 days) to goats either alone or in combination with cefquinome (2 mg/kg, IM, once a day for 5 days). The study was carried out on six goats according to a balanced, open, two-phase, cross-pharmacokinetic design. The plasma ketoprofen concentrations were measured using HPLC-UV, and the pharmacokinetic data were estimated using a non-compartmental analysis. After the first dose of ketoprofen, the terminal elimination half-life (t1/2ʎz), area under the plasma concentration-time curve (AUC0-last), and peak plasma concentration (Cmax) were 1.47 h, 12.23 h*μg/mL, and 6.06 μg/mL, respectively. The last dose of ketoprofen resulted in significant variations in t1/2ʎz and AUC0-last values compared to the first dose, but Cmax was similar. Cefquinome administration caused significant differences in the t1/2ʎz, AUC0-last, and Cmax of ketoprofen. There was no variation in Tmax between the first and final doses or between treatment groups. The accumulation ratio of ketoprofen was 1.32 and 0.76 when used alone and in combination with cefquinome, respectively. Repeated administration of ketoprofen alone or with cefquinome altered its disposition; therefore, the efficacy of ketoprofen when used alone or in combination with cefquinome in goats should be determined, and the dosage regimen should be re-evaluated.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.10
自引率
15.40%
发文量
69
审稿时长
8-16 weeks
期刊介绍: The Journal of Veterinary Pharmacology and Therapeutics (JVPT) is an international journal devoted to the publication of scientific papers in the basic and clinical aspects of veterinary pharmacology and toxicology, whether the study is in vitro, in vivo, ex vivo or in silico. The Journal is a forum for recent scientific information and developments in the discipline of veterinary pharmacology, including toxicology and therapeutics. Studies that are entirely in vitro will not be considered within the scope of JVPT unless the study has direct relevance to the use of the drug (including toxicants and feed additives) in veterinary species, or that it can be clearly demonstrated that a similar outcome would be expected in vivo. These studies should consider approved or widely used veterinary drugs and/or drugs with broad applicability to veterinary species.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信